Zobrazeno 1 - 10 of 34 pro vyhledávání: '"Rottinghaus ST"'
1
Akademický článek
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)
Autor: Kaiser K, Yount SE, Martens CE, Webster KA, Shaunfield S, Sparling A, Peipert JD, Cella D, Rottinghaus ST, Donato BMK, Wells R, Tomazos I
Publikováno v: Patient Preference and Adherence, Vol Volume 14, Pp 705-715 (2020)
Karen Kaiser,1 Susan E Yount,1 Christa E Martens,1 Kimberly A Webster,1 Sara Shaunfield,1 Amy Sparling,1 John Devin Peipert,1 David Cella,1 Scott T Rottinghaus,2 Bonnie MK Donato,2 Richard Wells,3 Ioannis Tomazos2 1Department of Medical Social Scienc
Externí odkaz: https://doaj.org/article/e1504a16e4924b06822c30f1c2bf100b
Zobrazit plný text záznamu
2
Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
Autor: Griffiths, CEM, Vender, R, Sofen, H, Kircik, L, Tan, H, Rottinghaus, ST, Bachinsky, M, Mallbris, L, Mamolo, C
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV, vol 31, iss 2
BackgroundTofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. A Phase 3 withdrawal/re-treatment study (NCT01186744; OPT Retreatment) showed tofacitinib re-treatment was effective in patients with chronic plaque psoriasis.O
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::cbd145c4536b389ad26b3bfe50e22ad7
https://escholarship.org/uc/item/91m1n5rt
Zobrazit plný text záznamu
3
Akademický článek
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight.
Autor: Hutmacher, MM, Papp, K, Krishnaswami, S, Ito, K, Tan, H, Wolk, R, Valdez, H, Mebus, C, Rottinghaus, ST, Gupta, P
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology; May2017, Vol. 6 Issue 5, p322-330, 9p
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
Autor: Brodsky RA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Peffault de Latour R; Université Paris Diderot and Hôpital Saint-Louis AP-HP, Paris., Rottinghaus ST; Alexion Pharmaceuticals, Inc., Boston, MA., Röth A; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen., Risitano AM; Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples., Weitz IC; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA., Hillmen P; Department of Haematology, St James's University Hospital, Leeds., Maciejewski JP; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Szer J; Clinical Haematology, Royal Melbourne Hospital, Melbourne., Lee JW; The Catholic University of Korea, College of Medicine, Seoul., Kulasekararaj AG; Department of Haematological Medicine, King College Hospital, London., Volles L; Alexion Pharmaceuticals, Inc., Boston, MA., Damokosh AI; Alexion Pharmaceuticals, Inc., Boston, MA., Ortiz S; Alexion Pharmaceuticals, Inc., Boston, MA., Shafner L; Alexion Pharmaceuticals, Inc., Boston, MA, USA., Liu P; Alexion Pharmaceuticals, Inc., Boston, MA., Hill A; Department of Haematology, St James's University Hospital, Leeds., Schrezenmeier H; German Red Cross Blood Transfusion Service, Baden-Wurttemberg-Hessen and University Hospital Ulm.
Publikováno v: Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 230-237. Date of Electronic Publication: 2021 Jan 01.
Zobrazit plný text záznamu
10
Akademický článek
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
Autor: Peffault de Latour R; French Reference Center for Aplastic Anemia and PNH Hematology-Bone Marrow Transplantation, Hôpital Saint-Louis AP-HP, Paris, France.; Université Paris Diderot, Paris, France., Brodsky RA; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ortiz S; Alexion Pharmaceuticals, Inc., Boston, MA, USA., Risitano AM; Hematology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy., Jang JH; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea., Hillmen P; Department of Haematology, St. James's University Hospital, Leeds, UK., Kulagin AD; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Kulasekararaj AG; Department of Haematological Medicine, King's College Hospital, NIHR/Wellcome King's Clinical Research Facility, London, UK., Rottinghaus ST; Alexion Pharmaceuticals, Inc., Boston, MA, USA., Aguzzi R; Alexion Pharmaceuticals, Inc., Boston, MA, USA., Gao X; Alexion Pharmaceuticals, Inc., Boston, MA, USA., Wells RA; Division of Medical Oncology and Haematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Szer J; Clinical Haematology at Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia.
Publikováno v: British journal of haematology [Br J Haematol] 2020 Nov; Vol. 191 (3), pp. 476-485. Date of Electronic Publication: 2020 May 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje